Share on StockTwits

Cyprotex plc (LON:CRX)‘s stock had its “corporate” rating reissued by analysts at N+1 Singer in a research report issued to clients and investors on Thursday.

Cyprotex plc (LON:CRX) traded down 3.85% on Thursday, hitting GBX 50.00. 46,401 shares of the company’s stock traded hands. Cyprotex plc has a 1-year low of GBX 50.00 and a 1-year high of GBX 82.50. The stock has a 50-day moving average of GBX 6.9 and a 200-day moving average of GBX 6.85.

Cyprotex PLC (LON:CRX) is a holding company specializing in preclinical ADME Tox, both in vitro (laboratory experiments) and in silico (computer modelling).

Receive News & Ratings for Cyprotex plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyprotex plc and related companies with Analyst Ratings Network's FREE daily email newsletter.